SQSTM1 and ovarian cancer: In terms of mechanism, SRT2183 has anti-ovarian cancer effects by activating the apoptosis pathway and increasing the level of LC3II, enhancing the degradation of p62/SQSTM1, and inducing the maturation of autophagosomes 205.